30 related articles for article (PubMed ID: 25423572)
1. Influence of oncogenic mutations and tumor microenvironment alterations on extranodal invasion in diffuse large B-cell lymphoma.
Shen R; Xu PP; Wang N; Yi HM; Dong L; Fu D; Huang JY; Huang HY; Janin A; Cheng S; Wang L; Zhao WL
Clin Transl Med; 2020 Nov; 10(7):e221. PubMed ID: 33252851
[TBL] [Abstract][Full Text] [Related]
2. KRAS and RAS-MAPK Pathway Deregulation in Mature B Cell Lymphoproliferative Disorders.
Vendramini E; Bomben R; Pozzo F; Bittolo T; Tissino E; Gattei V; Zucchetto A
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158933
[No Abstract] [Full Text] [Related]
3. Role of autoimmune hemolytic anemia as an initial indicator for chronic myeloid leukemia: A case report.
Li X; Cai S; Zhong Z; Wang H; Wang L; You Y; Zhang M
Medicine (Baltimore); 2020 Feb; 99(9):e19256. PubMed ID: 32118733
[TBL] [Abstract][Full Text] [Related]
4. Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.
Ollila TA; Olszewski AJ
Curr Treat Options Oncol; 2018 Jun; 19(8):38. PubMed ID: 29931605
[TBL] [Abstract][Full Text] [Related]
5. Primary Type3 (Non-ABC, Non-GCB) Subtype of Extranodal Diffuse Large B-Cell Lymphoma of the Thyroid Bearing No
Nishi Y; Kitazawa R; Haraguchi R; Ouchi A; Ueda Y; Kamaoka Y; Yamamoto K; Todo Y; Miyaoka H; Kitazawa S
Case Rep Oncol; 2017; 10(2):508-514. PubMed ID: 28690525
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic significance of MYD88 L265P mutation in diffuse large B-cell lymphoma: a meta-analysis.
Lee JH; Jeong H; Choi JW; Oh H; Kim YS
Sci Rep; 2017 May; 7(1):1785. PubMed ID: 28496180
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
8. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
9. FOXP1 protein overexpression is associated with inferior outcome in nodal diffuse large B-cell lymphomas with non-germinal centre phenotype, independent of gains and structural aberrations at 3p14.1.
Hoeller S; Schneider A; Haralambieva E; Dirnhofer S; Tzankov A
Histopathology; 2010 Jul; 57(1):73-80. PubMed ID: 20579129
[TBL] [Abstract][Full Text] [Related]
10. Thyroid carcinoma-associated genetic mutations also occur in thyroid lymphomas.
Aggarwal N; Swerdlow SH; Kelly LM; Ogilvie JB; Nikiforova MN; Sathanoori M; Nikiforov YE
Mod Pathol; 2012 Sep; 25(9):1203-11. PubMed ID: 22575864
[TBL] [Abstract][Full Text] [Related]
11. Array-comparative genomic hybridization profiling of immunohistochemical subgroups of diffuse large B-cell lymphoma shows distinct genomic alterations.
Guo Y; Takeuchi I; Karnan S; Miyata T; Ohshima K; Seto M
Cancer Sci; 2014 Apr; 105(4):481-9. PubMed ID: 24843885
[TBL] [Abstract][Full Text] [Related]
12. Marked genetic differences between BRAF and NRAS mutated primary melanomas as revealed by array comparative genomic hybridization.
Lázár V; Ecsedi S; Vízkeleti L; Rákosy Z; Boross G; Szappanos B; Bégány A; Emri G; Adány R; Balázs M
Melanoma Res; 2012 Jun; 22(3):202-14. PubMed ID: 22456166
[TBL] [Abstract][Full Text] [Related]
13. Detection of somatic quantitative genetic alterations by multiplex polymerase chain reaction for the prediction of outcome in diffuse large B-cell lymphomas.
Jardin F; Ruminy P; Kerckaert JP; Parmentier F; Picquenot JM; Quief S; Villenet C; Buchonnet G; Tosi M; Frebourg T; Bastard C; Tilly H
Haematologica; 2008 Apr; 93(4):543-50. PubMed ID: 18287131
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic mutations and chromosomal aberrations in primary extranodal diffuse large B-cell lymphomas of the thyroid--a study of 21 cases.
Knief J; Gebauer N; Bernard V; Schemme J; Reddemann K; Gebauer J; Rades D; Brabant G; Lehnert H; Feller AC; Thorns C
J Clin Endocrinol Metab; 2015 Feb; 100(2):754-62. PubMed ID: 25423572
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
